Angiogenesis as a target in rheumatoid arthritis.
Koch
A E
AE
Feinberg School of Medicine, Northwestern University and Veteran's Administration Chicago Healthcare System, Lakeside Division, IL 60611, USA. ae-koch@nwu.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D042501:Angiogenic Proteins / Q000502:physiology; D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D051379:Mice; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D013583:Synovial Membrane / Q000098:blood supply
D020533:Angiogenesis Inhibitors; D042501:Angiogenic Proteins; D018501:Antirheumatic Agents